PR Newswire
Neurimmune expands collaboration with AstraZeneca to develop and commercialize fibril depleter NI009 for AL amyloidosis
📈
AI Sentiment
Highly Positive
8/10
AstraZeneca PLC News
Latest updates and market news for AZN
20 news
Nov 29 - Dec 5, 2025
Page 1
Business Wire
AstraZeneca advances hematology and cell therapy ambition with largest-ever presence at ASH
📈
AI Sentiment
Highly Positive
8/10
Pharma Voice
BeOne brought Brukinsa to the blood cancer mountaintop. Can it hit those heights again?
📈
AI Sentiment
Highly Positive
8/10
Simply Wall St.
Is Vera Therapeutics (VERA) Quietly Recasting Its Commercial Strategy With the Meyers Board Appointment?
📊
AI Sentiment
Positive
6/10
Business Wire
Snowflake Doubles AWS Marketplace Growth YoY, Eclipses $2 Billion in Sales as New Integrations Accelerate Enterprise Data and AI Adoption
📈
AI Sentiment
Highly Positive
8/10
Zacks
AZN's Baxdrostat Gets FDA Priority Tag for Uncontrolled Hypertension
📊
AI Sentiment
Positive
7/10
Zacks
Why Astrazeneca (AZN) is a Top Momentum Stock for the Long-Term
📊
AI Sentiment
Positive
7/10
Business Wire
Owkin Announces International Validation Results of BRCAura: AI-Driven Screening for gBRCA Mutations Directly From Pathology Slides
📈
AI Sentiment
Highly Positive
8/10
Pharmaceutical Technology
Win for pharma in UK – zero US tariffs, VPAG rate cap and NICE threshold increase
📈
AI Sentiment
Highly Positive
8/10
Insider Monkey
AstraZeneca (AZN) Named One of BofA’s Top 25 Stocks for 2026
📈
AI Sentiment
Highly Positive
8/10
MT Newswires
Sector Update: Health Care Stocks Lower Tuesday Afternoon
âž–
AI Sentiment
Neutral
4/10
MT Newswires
Market Chatter: AstraZeneca, GSK to Join UK Working Group on New Drug-Pricing Framework
📊
AI Sentiment
Positive
6/10
Business Wire
Baxdrostat New Drug Application accepted under FDA Priority Review in the US for patients with hard-to-control hypertension
📈
AI Sentiment
Highly Positive
8/10
BioPharma Dive
Janux sinks on ‘overreaction’ to prostate cancer data; RFK Jr. replaces ACIP chair
âž–
AI Sentiment
Neutral
5/10
MT Newswires
Astrazeneca Obtains FDA Priority Review for Hypertension Drug Baxdrostat
📊
AI Sentiment
Positive
7/10
Fortune
There’s a ‘once-in-a-generation opportunity’ in these stocks right now, no matter how the AI boom ends, market veteran says
📊
AI Sentiment
Positive
7/10
GlobeNewswire
European Association for the Study of Diabetes (EASD) Annual Meeting Highlights 2025: Advancements in GLP-1RAs for Diabetes, Cardiovascular Treatments, and Therapies for Resistant Hypertension
📈
AI Sentiment
Highly Positive
8/10
GlobeNewswire
AIM ImmunoTech to Participate in Live ‘Fireside’ Chat on Virtual Investor Closing Bell Series
📊
AI Sentiment
Positive
7/10
Share this news page